Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status

Arch Neurol. 1989 Mar;46(3):261-4. doi: 10.1001/archneur.1989.00520390027010.

Abstract

Human immunodeficiency virus type-1 (HIV-1) antigen was assayed in paired serum/cerebrospinal fluid (CSF) specimen from 85 adults and 58 children with acquired immunodeficiency syndrome and was compared with clinical neurological status. A quantitative comparison of HIV-1 antigen levels in matched serum and CSF specimens indicated that HIV-1 antigen expression in these compartments is independent and is correlated with acquired immunodeficiency syndrome dementia complex in adults and progressive encephalopathy in children. In a longitudinal study (n = 47), 16 patients tested positive for HIV-1 antigen in the CSF before (n = 2) or coincident (n = 14) with neurological deterioration. Six patients who tested positive for HIV-1 antigen in the CSF remained neurologically normal for a median duration of follow-up of 11 months. Six of 25 patients who tested negative for HIV-1 antigen in the CSF, subsequently showed neurological deterioration. These data indicate that HIV-1 antigen expression in the CSF is not useful in predicting neurological deterioration.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / cerebrospinal fluid*
  • Acquired Immunodeficiency Syndrome / complications
  • Brain Diseases / etiology
  • Child
  • Child, Preschool
  • Dementia / etiology
  • HIV Antigens / cerebrospinal fluid*
  • Humans
  • Infant
  • Longitudinal Studies
  • Nervous System Diseases / etiology

Substances

  • HIV Antigens